British Journal of Cancer Friedlander, M, Matulonis, U, Gourley, C, Du Bois, A, Vergote, I, Rustin, G, Scott, C, Meier, W, Shapira-frommer, R, Safra, T, Matei, D, Shirinkin, V, Selle, F, Fielding, A, Lowe, E S, Mcmurtry, E L, Spencer, S, Rowe, P, Mann, H, Parry, D & Ledermann, J 2018, ' Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy ', British Journal of Cancer . https://doi.org/10.1038/s41416-018-0271-y
British Journal of Cancer Ledermann, J A, Harter, P, Gourley, C, Friedlander, M, Vergote, I, Rustin, G, Scott, C, Meier, W, Shapira-frommer, R, Safra, T, Matei, D, Fielding, A, Bennett, B, Parry, D, Spencer, S, Mann, H & Matulonis, U 2016, ' Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer ', British Journal of Cancer . https://doi.org/10.1038/bjc.2016.348
Hodgson, D R, Dougherty, B A, Lai, Z, Fielding, A, Grinsted, L, Spencer, S, O’connor, M J, Ho, T W, Robertson, J D, Lanchbury, J S, Timms, K M, Gutin, A, Orr, M, Jones, H, Gilks, B, Womack, C, Gourley, C, Ledermann, J & Barrett, J C 2018, ' Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes ', British Journal of Cancer . https://doi.org/10.1038/s41416-018-0274-8 British Journal of Cancer